Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in M exican patients: A randomized double‐blinded controlled trial
R Gomez‐Villa, F Aguilar‐Rebolledo… - Wound Repair and …, 2014 - Wiley Online Library
The healing process in diabetic foot ulcer (DFU) is hindered by factors such as chronic
inflammation, defects in fibroblast function, poor angiogenesis, and lack of cell migration …
inflammation, defects in fibroblast function, poor angiogenesis, and lack of cell migration …
Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: A randomized double-blinded controlled trial.
R Gomez‐Villa, F Aguilar‐Rebolledo… - Wound Repair & …, 2014 - search.ebscohost.com
The healing process in diabetic foot ulcer (DFU) is hindered by factors such as chronic
inflammation, defects in fibroblast function, poor angiogenesis, and lack of cell migration …
inflammation, defects in fibroblast function, poor angiogenesis, and lack of cell migration …
Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial.
R Gomez-Villa, F Aguilar-Rebolledo… - Wound Repair and …, 2014 - europepmc.org
A comment on this article appears in" Response to Uzun G et al." Wound Repair Regen.
2014 Nov-Dec; 22 (6): 767. A comment on this article appears in" Appropriate analysis and …
2014 Nov-Dec; 22 (6): 767. A comment on this article appears in" Appropriate analysis and …
Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial
R Gomez-Villa, F Aguilar-Rebolledo… - 2014 - pubmed.ncbi.nlm.nih.gov
The healing process in diabetic foot ulcer (DFU) is hindered by factors such as chronic
inflammation, defects in fibroblast function, poor angiogenesis, and lack of cell migration …
inflammation, defects in fibroblast function, poor angiogenesis, and lack of cell migration …
Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in M exican patients: A randomized double‐blinded controlled trial
R Gomez‐Villa, F Aguilar‐Rebolledo… - Wound Repair and …, 2014 - infona.pl
The healing process in diabetic foot ulcer (DFU) is hindered by factors such as chronic
inflammation, defects in fibroblast function, poor angiogenesis, and lack of cell migration …
inflammation, defects in fibroblast function, poor angiogenesis, and lack of cell migration …